The Role of Lipid Biomarkers in Major Depression
In the UK, the lifetime-documented prevalence of major depressive disorder (MDD) is currently 10%. Despite its increasing prevalence and devastating impact on quality of life, the pathophysiological mechanisms underpinning MDD remain to be fully elucidated. Current theories of neurobiological compon...
Main Authors: | Amy Parekh, Demelza Smeeth, Yasmin Milner, Sandrine Thuret |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9032/5/1/5 |
Similar Items
-
A controlled study on serum lipid parameters in individuals with and without major depressive disorder
by: Bilal Ahmad Bhat, et al.
Published: (2020-01-01) -
A study on serum lipid parameters in individuals with major depressive disorder in comparison to normal controls
by: Bilal Ahmad Bhat, et al.
Published: (2020-01-01) -
Prospective plasma lipid profiling in individuals with and without depression
by: Dietmar Enko, et al.
Published: (2018-06-01) -
Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
by: Bai S, et al.
Published: (2021-02-01) -
Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder
by: Maud Tastevin, et al.
Published: (2020-10-01)